Saudi SASO Updates Energy Efficiency Standard for Medical RO Water Systems

Saudi Arabia’s Standards, Metrology and Quality Organization (SASO) officially updated its mandatory standard for medical reverse osmosis (RO) water systems on May 1, 2026. The revision introduces two new mandatory test requirements — minimum water recovery rate of ≥90% and maximum total organic carbon (TOC) residue of ≤0.1 ppb — both now required in type-approval testing. Exporters of medical RO water systems to Saudi Arabia must submit test reports covering both metrics for all new orders placed from June 2026 onward. This development is particularly relevant for manufacturers, exporters, and regulatory compliance teams serving the medical device and hospital infrastructure sectors.

Event Overview

On May 1, 2026, SASO issued an updated mandatory standard for Medical RO Water Systems. The update adds two new mandatory performance indicators to the existing energy efficiency framework: (1) a minimum water recovery rate of 90%, and (2) a maximum total organic carbon (TOC) residue level of 0.1 ppb. Both parameters are now included as compulsory items in type-approval testing. The requirement applies to all manufacturers exporting such systems to Saudi Arabia. As of June 2026, new export orders must be accompanied by test reports verifying compliance with both metrics.

Industries Affected

Medical Device Exporters & OEMs

Exporters and original equipment manufacturers supplying medical RO water systems to Saudi healthcare facilities face direct compliance obligations. The new TOC and recovery rate requirements necessitate revalidation of system design, membrane selection, and post-treatment configurations. Non-compliant units may be rejected at customs or fail local conformity assessment.

RO System Component Suppliers

Suppliers of high-efficiency membranes, TOC-removal modules (e.g., UV-oxidation + polishing resin), and precision flow control components may see increased demand. However, component-level specifications must now align with system-level validation — meaning suppliers must provide traceable performance data supporting end-system TOC and recovery claims.

Regulatory Compliance & Certification Service Providers

Certification bodies accredited for SASO CoC (Certificate of Conformity) and SASO IECEE CB Scheme assessments must update their test protocols and laboratory capabilities to cover TOC residue measurement (per ISO 8573-5 or ASTM D5903) and dynamic recovery rate evaluation under medical-grade operational conditions (e.g., continuous 24-hour testing at rated capacity).

Hospital Infrastructure Integrators

Integrators specifying or installing medical RO water systems in Saudi hospitals must verify supplier documentation against the updated SASO standard prior to procurement. Procurement contracts signed after May 2026 should explicitly reference compliance with the revised version, including third-party test reports for both metrics.

Key Considerations and Recommended Actions

Monitor official SASO documentation updates

While the effective date and scope are confirmed, SASO has not yet published the full technical annexes detailing test methodology, sampling frequency, or acceptable uncertainty margins. Exporters should track SASO’s official portal and notify their certification partners to flag any revisions to test procedure documents before June 2026.

Validate current product lines against both new metrics

Manufacturers should prioritize internal or third-party testing of existing models — especially those with multi-stage polishing or variable-flow designs — to identify gaps in TOC removal efficiency or recovery rate consistency. Systems previously certified under older SASO versions do not grandfather the new requirements.

Update technical documentation and labeling

Product datasheets, user manuals, and Declaration of Conformity statements must reflect compliance with the updated standard. Claims regarding ‘medical-grade purity’ or ‘ultra-low TOC’ now require substantiation via SASO-recognized test reports — generic lab certificates will no longer suffice for CoC issuance.

Engage early with SASO-accredited labs

Lead times for TOC residue testing (requiring ultra-trace analytical capability) and extended-duration recovery validation are currently increasing. Firms placing new orders after June 2026 should initiate test scheduling with accredited laboratories no later than mid-May 2026 to avoid shipment delays.

Editorial Perspective / Industry Observation

This update is observably less about incremental energy efficiency and more about tightening clinical water quality assurance. While labeled a ‘energy efficiency standard’ update, the inclusion of TOC — a key indicator of biofilm risk and endotoxin precursor load — signals SASO’s alignment with international medical water standards (e.g., USP <1231>, ISO 13485 process water clauses). Analysis shows the dual-metric requirement reflects growing emphasis on system reliability over nominal output. It is better understood as a regulatory signal — not yet a fully implemented enforcement wave — since SASO has not announced transitional arrangements or audit timelines beyond the June order cutoff. Continued observation is warranted for how local conformity assessment bodies interpret ‘medical use’ scope (e.g., whether dialysis-only units fall under this rule).

In summary, the SASO update marks a procedural shift toward outcome-based verification for medical RO water systems entering Saudi Arabia. It does not represent a broad market barrier, but rather a targeted calibration of technical expectations for products used in critical care environments. Current implementation remains focused on documentation and pre-shipment validation — not retroactive recalls or facility audits. For stakeholders, this is best interpreted as a compliance milestone requiring targeted technical readiness, not a strategic pivot.

Source: SASO Official Announcement (May 1, 2026); SASO Standard No. SASO IEC 60601-2-62 (Amendment 1, 2026 Edition).
Note: Test methodology annexes and enforcement guidance remain pending; ongoing monitoring recommended.